| scholarly article | Q13442814 |
| P2093 | author name string | Gilbert J L'Italien | |
| Carol E Koro | |||
| Donald O Fedder | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 152-156 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population | |
| P478 | volume | 105 |
| Q35150514 | 34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap? |
| Q35150530 | 34th Bethesda Conference: Task force #5--Is atherosclerosis imaging cost effective? |
| Q46578793 | Acute and chronic effects of vitamin C on endothelial fibrinolytic function in overweight and obese adult humans |
| Q92098361 | Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia |
| Q40306023 | Application of national screening criteria for blood pressure and cholesterol to perimenopausal women: prevalence of hypertension and hypercholesterolemia in the Study of Women's Health Across the Nation |
| Q24794337 | Assessing compliance of cardiologists with the national cholesterol education program (NCEP) III guidelines in an ambulatory care setting |
| Q39649055 | Assessment of Global Coronary Heart Disease Risk in Overweight and Obese African‐American Women |
| Q24795084 | Beyond the Evidence of the New Hypertension Guidelines. Blood pressure measurement - is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I) |
| Q46619645 | Blood Pressure Regulation: Reviewing Evidence for Interplay Between Common Dietary Sugars and Table Salt |
| Q35223745 | CD31+ T cells, endothelial function and cardiovascular risk |
| Q28186232 | Clinical utility of coronary calcium scoring after nonischemic myocardial perfusion imaging |
| Q34164321 | Coronary Risk Assessment by Point-Based vs. Equation-Based Framingham Models: Significant Implications for Clinical Care |
| Q44688543 | Coronary calcium screening in asymptomatic patients as a guide to risk factor modification and stress myocardial perfusion imaging |
| Q46917703 | Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function |
| Q36412316 | Cost-utility analysis of a national project to reduce hypertension in Israel |
| Q40585105 | Costs of dyslipidemia |
| Q36203999 | Effects of Adherence to Statin Therapy on Health Care Outcomes and Utilizations in Taiwan: A Population-Based Study |
| Q46572738 | Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise |
| Q35314860 | Enhanced endothelin-1 system activity with overweight and obesity |
| Q44804875 | Ezetimibe: a novel option for lowering cholesterol |
| Q33965047 | Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals |
| Q44259003 | Identification of gene-selective modulators of the bile acid receptor FXR. |
| Q34971125 | Impaired aortic distensibility measured by computed tomography is associated with the severity of coronary artery disease |
| Q36938950 | Impaired endothelium-dependent vasodilation in overweight and obese adult humans is not limited to muscarinic receptor agonists |
| Q34704310 | Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia |
| Q84520798 | Influence of abdominal obesity on vascular endothelial function in overweight/obese adult men |
| Q37350166 | Is a statin as part of a polypill the answer? |
| Q44171842 | Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes |
| Q36880464 | Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults |
| Q46733944 | National Cholesterol Education Panel III performance in preventing myocardial infarction in young adults |
| Q24810059 | National trends in statin use by coronary heart disease risk category |
| Q44412315 | New features of the national cholesterol education program adult treatment panel III lipid-lowering guidelines |
| Q36475343 | Overcoming 'ageism' bias in the treatment of hypercholesterolaemia : a review of safety issues with statins in the elderly |
| Q36555257 | Overprescribing of lipid lowering agents |
| Q90445373 | Pharmacological Options in Atherosclerosis: A Review of the Existing Evidence |
| Q35125696 | Preventing myocardial infarction in the young adult in the first place: how do the national cholesterol education panel iii guidelines perform? |
| Q28192987 | Primary prevention of coronary heart disease? What is cost effective in the clinical practice? |
| Q37085308 | Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids |
| Q94555779 | Reaching goal: Conquering the treatment gaps in dyslipidemia management |
| Q34849588 | Renin-angiotensin system antagonism and lipid-lowering therapy in cardiovascular risk management |
| Q35696163 | Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia |
| Q34628565 | Statins: balancing benefits, efficacy and safety |
| Q35967383 | Statins: can the new generation make an impression? |
| Q80809911 | The case for statins: has it really been made? |
| Q55359870 | The clinical and nonclinical values of nonexercise estimation of cardiovascular endurance in young asymptomatic individuals. |
| Q35828802 | The importance of aggressive lipid management in patients at risk: evidence from recent clinical trials. |
| Q36014640 | The role of pharmacoepidemiology and pharmacoeconomics in promoting access and stimulating innovation |
| Q35050130 | Therapy to reduce risk of coronary heart disease. |
| Q34657896 | Trends in low-density lipoprotein cholesterol goal achievement in high risk United States adults: longitudinal findings from the 1999-2008 National Health and Nutrition Examination Surveys |
| Q35549732 | Update on the National Cholesterol Education Program Adult Treatment Panel III Guidelines: Getting to Goal |
| Q93080977 | Whey Protein Supplementation Compared to Collagen Increases Blood Nesfatin Concentrations and Decreases Android Fat in Overweight Women: A Randomized Double-Blind Study |
Search more.